Padagis Nitroglycerin Spray Recall: Defective Delivery System Risk
Padagis recalls nitroglycerin lingual spray (400 mcg per spray) due to defective delivery system. This may cause improper dosing. Check NDC 45802-210-02 and lot numbers for affected units.
Use caution until it’s fixed
Defective Delivery System
Contact the company
What happened, in plain English
Padagis is recalling nitroglycerin lingual spray that may have a defective delivery system. This could lead to improper dosing of the medication, which is serious for people with heart conditions. Read more at govinfonow.com/recall/35415-padagis-nitroglycerin-spray-recall-defective-delivery-system-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/35415-padagis-nitroglycerin-spray-recall-defective-delivery-system-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0372-2022
Cite this page
“Padagis Nitroglycerin Spray Recall: Defective Delivery System Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35415-padagis-nitroglycerin-spray-recall-defective-delivery-system-risk. Based on FDA recall #D-0372-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0372-2022%22&limit=1).
Why it’s dangerous
The spray's delivery system may not function properly, leading to incorrect medication doses. This could be dangerous for individuals with heart conditions who rely on the spray for chest pain relief.
Who’s affected
People with heart conditions who use prescription nitroglycerin spray for chest pain. Those who have the specific lot numbers listed in the recall are most at risk.
How to tell if you have this one
Check the product label for NDC 45802-210-02 and lot numbers: 150892 (expires Oct 2022), 153199 (expires Feb 2023), or 156041 (expires Apr 2023).
- Brand
Padagis- Category
Drug
What to do — step by step
Check Product Label
Look for NDC 45802-210-02 and lot numbers 150892, 153199, or 156041 on the spray bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 21 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0372-2022 (December 27, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0372-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.